Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Plos One|December 17, 2020
C/EBPα induces Ebf1 gene expression in common lymphoid progenitorsTheresa Barberi, Cheng Cui, Alan D FriedmanCancer Immunology, Immunotherapy : CII|February 4, 2025
PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progenyMohammad A Alzubi, Theresa Barberi, Alan D FriedmanJournal of Immunology (Baltimore, Md. : 1950)|August 1, 2018
Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPαHong Guo, Theresa Barberi, Rahul Suresh, et al.Molecular Oncology|January 22, 2021
Adoptive transfer of immature myeloid cells lacking NF-κB p50 (p50-IMC) impedes the growth of MHC-matched high-risk neuroblastomaCheng Cui, Theresa Barberi, Rahul Suresh, et al.Plos One|January 12, 2018
Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cellsDavid J Barakat, Rahul Suresh, Theresa Barberi, et al.Journal for Immunotherapy of Cancer|January 16, 2020
NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinomaRahul Suresh, David J Barakat, Theresa Barberi, et al.Cancer Letters|March 13, 2016
C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusionDavid J Barakat, Janet Mendonca, Theresa Barberi, et al.Cancer Immunology, Immunotherapy : CII|July 22, 2018
Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarizationTheresa Barberi, Allison Martin, Rahul Suresh, et al.International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.Pageof 1